StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Profenamin

(+-)-Ethopropazine

HCID 3290
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
1094-08-2
Standard-SMILES
CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21
InChIKey
CDOZDBSBBXSXLB-UHFFFAOYSA-N
Summenformel
C19H24N2S
Durchschnittliche Molmasse
312,5 g/mol
Monoisotopische Masse
312,16601995

Überblick

Profenamine is a member of the class of phenothiazines that is phenothiazine in which the hydrogen attached to the nitrogen is substituted by a 2-(diethylamino)propyl group. An antimuscarinic, it is used as the hydrochloride for the symptomatic treatment of Parkinson's disease. It has a role as an adrenergic antagonist, a histamine antagonist, an antiparkinson drug, a muscarinic antagonist and an antidyskinesia agent. It is a member of phenothiazines and a tertiary amino compound.

Namen und Bezeichner

Bevorzugter Name
(+-)-Ethopropazine
IUPAC
N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine
Lokaler Name
Profenamin
Englischer Name
ETHOPROPAZINE
Summenformel
C19H24N2S
Molmasse
312.47226

Namen und Synonyme

ethopropazineProfenamineEthopromazine522-00-9ProfenaminumProfenamina2-Diethylamino-1-propyl-N-dibenzoparathiazineN,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamineW-483RP-3356SC-25387WI4P02YN1
Weitere Namen anzeigen
ParkinparkTomilsc2538rp3356RP 3356RodipalRocipel
(+-)-Ethopropazine10-[2-(Diethylamino)propyl]phenothiazine10-[2-(Diethylamino)-1-Propyl]phenothiazine10H-Phenothiazine-10-ethanamine, N,N-diethyl-alpha-methyl-10-[2-(Diethylamino)-2-methylethyl]phenothiazinePHENOTHIAZINE, 10-(2-(DIETHYLAMINO)PROPYL)-diethyl[1-(10H-phenothiazin-10-yl)propan-2-yl]amineN,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine

Datenbank-Bezeichner

CAS
1094-08-2、522-00-9
PubChem CID
3290
DTXSID
DTXSID2023018
ChEMBL
CHEMBL1206
ChEBI
CHEBI:313639
UNII
7WI4P02YN1
EC Number
208-320-4
Nikkaji
J2.060E

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
4,8
Polarare Oberfläche (TPSA)
31,8 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
5
Schwere Atome
22
Formalladung
0
Komplexität
322

Experimentelle und physikochemische Eigenschaften

LogP · 2 Einträge

5.2

4.77

Solubility5.24e-03 g/L
Human DrugsPharmaceuticals
Melting Point · 2 Einträge

166-168

64.5 °C

Physical DescriptionSolid
Collision Cross Section174.37 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
53 · 53-55°
Dichte
1.107 · 1.1070 (rough estimate)
Brechungsindex
1.58 · 1.5800 (estimate)
storage temp.
-20 °C · -20°C

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

N - Nervous system

QN - Nervous system

Protein Binding93%
Pharmacodynamics · 1 Eintrag

Profenamine, a phenothiazine and antidyskinetic, is used in the treatment of Parkinson's disease. By improving muscle control and reducing stiffness, this drug permits more normal movements of the body as the disease symptoms are reduced. It is also used to control severe reactions to certain medicines such as reserpine, phenothiazines, chlorprothixene, thiothixene, loxapine, and haloperidol. Unlike other NMDA antagonists, profenamine — because of its anticholinergic action — is largely devoid of neurotoxic side effects. Profenamine also has a slight antihistaminic and local anesthetic effect.

Mechanism of Action · 1 Eintrag

Profenamine's anti-Parkinson action can be attributed to its anticholinergic properties. Profenamine partially blocks central (striatal) cholinergic receptors, thereby helping to balance cholinergic and dopaminergic activity in the basal ganglia; salivation may be decreased, and smooth muscle may be relaxed. Drug-induced extrapyramidal symptoms and those due to parkinsonism may be relieved, but tardive dyskinesia is not alleviated and may be aggravated by anticholinergic effects. Profenamine's local anesthetic effect is due to its antagonism of the NMDA glutamate receptor. Glutamate is recognized as an important transmitter in nociceptive pathways, and the N-methyl-D-aspartate (NMDA) subtype of the glutamate receptor, in particular, has been implicated in the mediation of neuropathic pain. Excessive release of glutamate at NMDA receptors on dorsal horn neurons of the spinal cord results in hyperactivation and hypersensitivity of these receptors (perceived as hyperalgesia), thought to be an integral feature of neuropathic pain.

Biological Half-Life1 to 2 hours
MeSH Pharmacological Classification · 3 Einträge

Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only.

Drugs that bind to but do not activate ADRENERGIC RECEPTORS. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters EPINEPHRINE and NOREPINEPHRINE.

Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system.

Absorption, Distribution and ExcretionWell-absorbed from the gastrointestinal tract.
Cellular LocationsCytoplasm

Verwendung und Herstellung

Use ClassificationPharmaceuticals

Anwendungen

Verwendenantiparkinsonian, anticholinergic

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

HydrogenchloridMagnesiumMethyljodidPhenothiazin
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: A member of the class of phenothiazines that is phenothiazine in which the hydrogen attached to the nitrogen is substituted by a 2-(diethylamino)propyl group. An antimuscarinic, it is used as the hydrochloride for the symptomatic treatment of Parkinson's d sease.

Zugehörige Reaktionen

1
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 473792
HRID 473792als Produkt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung